Literature DB >> 6159973

Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.

B T Hill, R D Whelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159973     DOI: 10.1016/s0305-7372(80)80002-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  7 in total

1.  The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.

Authors:  A T McGown; D G Poppitt; R Swindell; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Reduction of the local toxicity of intraperitoneal chemotherapy; an experimental model.

Authors:  R G Molloy; B Crowley; K T Moran; M P Brady
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

3.  Experimental in vivo cross-resistance of vinca alkaloid drugs.

Authors:  R Maral; C Bourut; E Chenu; G Mathe
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Plasma spermidine concentrations as early indication of response to therapy in human myeloma.

Authors:  O A Van Dobbenburgh; B Houwen; H Jurjens; J Marrink; M R Halie; H O Nieweg
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

Review 5.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

6.  Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.

Authors:  O van Tellingen; A V Kuijpers; J H Beijnen; W J Nooijen; A Bult
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

7.  Cytotoxicity of etretinate and vindesine.

Authors:  J M Gaukroger; L Wilson; R MacKie
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.